Skip to main content

New Pfizer Covid Pill Could Be a Gamechanger for Biotech ETFs

Although there is significant optimism surrounding the coronavirus vaccine rollout, recent developments show that 21 states are actually experiencing an increase in infections, generating concern among researchers and government leaders. To that end, Pfizer announced Tuesday it has commenced an...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.